Rani Therapeutics Holdings, Inc. (RANI)
0.6406
-0.04
(-5.79%)
USD |
NASDAQ |
Oct 16, 16:00
0.6392
0.00 (0.00%)
After-Hours: 20:00
Rani Therapeutics Holdings Market Cap : 72.07M for Oct. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 72.07M |
| October 15, 2026 | 76.50M |
| October 14, 2026 | 75.40M |
| October 13, 2026 | 82.48M |
| October 12, 2026 | 84.48M |
| October 09, 2026 | 89.89M |
| October 08, 2026 | 89.10M |
| October 07, 2026 | 91.36M |
| October 06, 2026 | 93.24M |
| October 05, 2026 | 87.18M |
| October 02, 2026 | 91.21M |
| October 01, 2026 | 89.49M |
| September 30, 2026 | 88.99M |
| September 29, 2026 | 90.03M |
| September 28, 2026 | 87.30M |
| September 25, 2026 | 85.41M |
| September 24, 2026 | 84.26M |
| September 23, 2026 | 86.29M |
| September 22, 2026 | 87.51M |
| September 21, 2026 | 88.81M |
| September 18, 2026 | 96.97M |
| September 17, 2026 | 95.80M |
| September 16, 2026 | 85.05M |
| September 15, 2026 | 92.42M |
| September 14, 2026 | 94.03M |
| Date | Value |
|---|---|
| September 11, 2026 | 94.79M |
| September 10, 2026 | 92.47M |
| September 09, 2026 | 94.50M |
| September 08, 2026 | 98.16M |
| September 04, 2026 | 97.35M |
| September 03, 2026 | 95.87M |
| September 02, 2026 | 96.52M |
| September 01, 2026 | 97.26M |
| August 31, 2026 | 96.05M |
| August 28, 2026 | 94.50M |
| August 27, 2026 | 96.10M |
| August 26, 2026 | 94.66M |
| August 25, 2026 | 100.24M |
| August 24, 2026 | 98.89M |
| August 21, 2026 | 99.00M |
| August 20, 2026 | 95.74M |
| August 19, 2026 | 103.12M |
| August 18, 2026 | 92.86M |
| August 17, 2026 | 89.54M |
| August 14, 2026 | 89.56M |
| August 13, 2026 | 89.76M |
| August 12, 2026 | 90.31M |
| August 11, 2026 | 88.31M |
| August 10, 2026 | 77.54M |
| August 07, 2026 | 79.05M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 14.06M |
| CNBX Pharmaceuticals, Inc. | 0.2214M |
| Arvinas, Inc. | 455.14M |
| Fulcrum Therapeutics, Inc. | 278.44M |
| Definium Therapeutics, Inc. | 4.313B |
Market Cap Related Metrics
| PS Ratio | 18.41 |
| Price to Book Value | 1.837 |
| Price | 0.6406 |
| Earnings Yield | -41.40% |